| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |